An ethanolic extract of Angelica gigas improves atherosclerosis by inhibiting vascular smooth muscle cell proliferation.
- Author:
Ja Young JANG
1
;
Jihyun KIM
;
Jingmei CAI
;
Youngeun KIM
;
Kyungha SHIN
;
Tae Su KIM
;
Sung Pyo LEE
;
Sung Kyeong PARK
;
Ehn Kyoung CHOI
;
Yun Bae KIM
Author Information
- Publication Type:Letter
- Keywords: Hypercholesterolemia; atherosclerosis; vascular smooth muscle cell proliferation; Angelica gigas
- MeSH: Angelica*; Animals; Atherosclerosis*; Cell Proliferation*; Cholesterol; Diet; DNA; Ethanol*; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Muscle, Smooth, Vascular*; Plaque, Atherosclerotic; Rabbits; Rats; Thymidine
- From:Laboratory Animal Research 2014;30(2):84-89
- CountryRepublic of Korea
- Language:English
- Abstract: The effects of an ethanolic extract of Angelica gigas (EAG) on the vascular smooth muscle cell (VSMC) proliferation and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis were investigated. Rat aortic VSMCs were stimulated with platelet-derived growth factor-BB (25 ng/mL) for the induction of DNA synthesis and cell proliferation. EAG (1-10 microg/mL) significantly inhibited both the thymidine incorporation and cell proliferation in a concentration-dependent manner. Hypercholesterolemia was induced by feeding male New Zealand white rabbits with 0.5% cholesterol in diet for 10 weeks, during which EAG (1% in diet) was given for the final 8 weeks after 2-week induction of hypercholesterolemia. Hypercholesterolemic rabbits exhibited great increases in serum total cholesterol and low-density lipoproteins (LDL) levels, and finally severe atheromatous plaque formation covering 28.4% of the arterial walls. EAG significantly increased high-density lipoproteins (HDL), slightly decreased LDL, and potentially reduced the atheroma area to 16.6%. The results indicate that EAG attenuates atherosclerosis not only by inhibiting VASC proliferation, but also by increasing blood HDL levels. Therefore, it is suggested that EAG could be an alternative or an adjunct therapy for the improvement of hypercholesterolemia and atherosclerosis.
